Early Development Still Driving CRO Performance

Published on: 
Pharmaceutical Technology, Pharmaceutical Technology-09-02-2004, Volume 28, Issue 9

Early development services continue to be a sweet spot for contract R&D services. The big question is how soon the impact of early-development candidates will be felt in late development and commercialization.

Related Content:

Bio/Pharma BusinessOutsourcingOutsourcing OutlookContract Manufacturing, GeneralPharmaceutical Technology-09-02-2004
Charles River to Provide pDNA Manufacturing Services in Two Deals
Lonza Forms Agreement to Manufacture Acumen Pharmaceuticals’ AD mAb Therapy
Genmab Expands ADC Pipeline with $1.8 Billion Acquisition of ProfoundBio